# US Brain Imaging Neuroimaging Market > US Brain Imaging Neuroimaging Market Research Report: By Imaging Type (Functional Magnetic Resonance Imaging (FMRI), Compound Tomography (CT), Positron Emission Tomography (PET), Electroencephalography (EEG), Magnetoencephalography (MEG), Near Infrared Spectroscopy (NIRS)) and By End User (Hospitals, Ambulatory Surgical Centers, Clinics, Diagnostic Centers) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 5.79% - **2024:** $ 3,500 Million - **2025:** $ 3,702.65 Million - **2035:** $ 6,500 Million - **Key Players:** Siemens Healthineers (DE), GE Healthcare (US), Philips Healthcare (NL), Canon Medical Systems (JP), Hitachi Medical Corporation (JP), NeuroLogica Corporation (US), Medtronic (US), Brainlab (DE), Elekta (SE) **Report ID:** MRFR/MED/15220-HCR · **Pages:** 100 · **Author:** Nidhi Mandole & Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-brain-imaging-neuroimaging-market-16748 --- ## Market Summary ## **US Brain Imaging Neuroimaging Market Overview** As per MRFR analysis, the US Brain Imaging Neuroimaging Market Size was estimated at 3.62 (USD Billion) in 2023. The US Brain Imaging Neuroimaging Market Industry is expected to grow from 4 (USD Billion) in 2024 to 8 (USD Billion) by 2035. The US Brain Imaging Neuroimaging Market CAGR (growth rate) is expected to be around 6.504% during the forecast period (2025 - 2035). ### **Key US Brain Imaging Neuroimaging Market Trends Highlighted** The US Brain Imaging Neuroimaging Market is experiencing significant growth due in large part to advancements in technology and increasing demand for precise diagnostic tools. Key market drivers include the rising prevalence of neurological disorders such as Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis, which are prompting the need for effective imaging solutions. Additionally, an aging population in the US is further fueling the need for comprehensive brain imaging assessments, as older adults are more susceptible to cognitive impairments. Opportunities to be explored involve the integration of artificial intelligence with neuroimaging techniques, which can enhance accuracy and efficiency in diagnosis. Innovations in imaging modalities such as functional MRI and PET scans are creating avenues for better detection and monitoring of neurological conditions. Furthermore, the growing collaboration between academic institutions and healthcare providers is paving the way for groundbreaking research and development in brain imaging technologies. Trends in recent times highlight a shift towards non-invasive imaging methods, with increased emphasis on patient comfort and reduced exposure to radiation. The expanding role of telemedicine in the US health system is also influencing brain imaging practices, facilitating remote consultations and assessments. As healthcare providers seek to improve access to care, the demand for portable and user-friendly imaging devices is on the rise. Overall, the US Brain Imaging Neuroimaging Market is poised for dynamic growth, driven by technological innovation, changing demographics, and evolving healthcare needs. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **US Brain Imaging Neuroimaging Market Drivers** ### **Increasing Incidence of Neurological Disorders** The prevalence of neurological disorders is steadily increasing in the United States, creating a significant demand for brain imaging technologies. According to the Centers for Disease Control and Prevention (CDC), approximately 1 in 6 people in the US are affected by neurological diseases such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis. This alarming statistic results in more individuals seeking diagnostic neuroimaging solutions for early detection and intervention. Leading organizations, including the American Academy of Neurology, are advocating for enhanced neuroimaging capabilities to facilitate better patient outcomes. The rise in neurological conditions has thus established a strong driver for the growth of the US Brain Imaging Neuroimaging Market Industry as healthcare providers look to implement advanced imaging techniques to improve diagnosis, aid in treatment planning, and monitor disease progression. ### **Technological Advancements in Imaging Techniques** Rapid advancements in imaging technologies, such as Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET), are transforming the landscape of neuroimaging. The National Institute of Health (NIH) has reported a significant increase in the development of high-resolution imaging systems, which enhance the aesthetic and functional analysis of brain structures. These innovations are supported by institutions like Siemens Healthineers and GE Healthcare, which are continuously investing in Research and Development (R&D) to enhance imaging quality and reduce examination times. The introduction of more sophisticated imaging modalities, including functional MRI and diffusion tensor imaging, is driving the US Brain Imaging Neuroimaging Market Industry forward as healthcare professionals seek to leverage these advanced tools for better patient care and improved clinical outcomes. ### **Growing Aging Population** The aging population in the United States is projected to significantly contribute to the growth of the US Brain Imaging Neuroimaging Market Industry. By 2030, it is estimated that around 20% of the US population will be 65 years or older, according to the United States Census Bureau. As age is a major risk factor for various neurological disorders, including dementia and stroke, the demand for neuroimaging services is expected to rise sharply in this demographic. Prominent healthcare organizations like the Alzheimer’s Association are emphasizing the necessity of neuroimaging in the care and treatment strategies for the elderly, further boosting market growth. As healthcare systems strive to manage the implications of an aging population, innovative neuroimaging technologies will play a pivotal role in diagnosing and treating age-related neurological conditions. ### **Increased Investment in Healthcare Infrastructure** The US government and private sectors are accelerating investments in healthcare infrastructure, particularly in advanced diagnostic tools such as neuroimaging technologies. The US Department of Health and Human Services allocated substantial funding towards the Improving the Health of Americans initiative which underscores the importance of enhancing healthcare services through state-of-the-art technologies. Organizations such as the American Hospital Association report that hospitals are increasingly prioritizing investments in neuroimaging equipment to cater to the growing patient demand. As healthcare facilities upgrade their technologies and expand their capabilities, the US Brain Imaging Neuroimaging Market Industry is likely to experience accelerated growth driven by the heightened focus on advanced diagnostic solutions. ## **US Brain Imaging Neuroimaging Market Segment Insights** ### **Brain Imaging Neuroimaging Market Imaging Type Insights** The Imaging Type segment of the US **[Brain Imaging Neuroimaging Market](../../../reports/brain-imaging-neuroimaging-market-12265)**encompasses several innovative technologies that play a pivotal role in diagnosing and monitoring neurological conditions. Each imaging modality brings its unique capabilities, contributing to a comprehensive understanding of brain function and structure. Functional Magnetic Resonance Imaging (FMRI) is particularly significant as it allows researchers and clinicians to visualize brain activity in real-time by measuring changes in blood flow, thus supporting both clinical outcomes and academic research in cognitive neuroscience. Similarly, Compound Tomography (CT) is widely recognized for its ability to quickly assess brain injuries and conditions, making it an essential tool in emergency medicine within the US healthcare system. Positron Emission Tomography (PET) excels in detecting metabolic processes and has proven invaluable for oncology and understanding neurodegenerative diseases, further highlighting its segment's importance. Electroencephalography (EEG) provides essential insights into electrical activity in the brain, making it crucial for the assessment of epilepsy and sleep disorders, thus addressing a critical area in mental health diagnostics. Meanwhile, Magnetoencephalography (MEG) offers high temporal resolution, allowing researchers to track brain activities with precision, which is especially useful in pre-surgical planning for epilepsy and brain tumors. Near Infrared Spectroscopy (NIRS) is gaining traction due to its non-invasive nature and applicability in monitoring brain oxygen levels in neonates and patients undergoing cognitive rehabilitation. The diversity within the Imaging Type segment showcases ongoing advancements and drives market growth, with each modality contributing uniquely to the overall landscape of brain imaging, thus meeting the evolving demands of healthcare and research in the US. The collective strengths of these imaging techniques underline the critical need for ongoing investment in technology and innovation to improve diagnostic accuracy and patient outcomes. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Brain Imaging Neuroimaging Market End User Insights** The End User segment of the US Brain Imaging Neuroimaging Market encompasses various healthcare settings where neuroimaging plays a critical role in patient diagnosis and treatment. Hospitals are essential in this landscape, serving as primary facilities for advanced imaging technologies, housing specialized departments that perform MRI, CT scans, and PET scans for comprehensive patient care. Ambulatory Surgical Centers are gaining traction due to their capacity to provide efficient surgical procedures and outpatient care, along with neuroimaging services that enhance surgical planning. Clinics also contribute significantly, often focusing on outpatient neuroimaging that caters to patients seeking diagnosis without extensive hospital stays. Diagnostic Centers, meanwhile, are pivotal in funneling patients towards specialized imaging services, allowing for early detection and management of neurological conditions. This diverse utilization of neuroimaging across these different End Users highlights the interconnectedness of patient care and technology in the US healthcare landscape, driven by trends such as an aging population and a rising incidence of neurological disorders, further emphasizing the importance of these facilities in advancing brain imaging capabilities. ## **US Brain Imaging Neuroimaging Market Key Players and Competitive Insights** The US Brain Imaging Neuroimaging Market is characterized by rapid advancements in technology, resulting in innovative solutions that enhance diagnostic accuracy and patient outcomes. The competitive landscape is populated by several key players, each vying for market share through unique product offerings and strategic collaborations. As the healthcare industry increasingly recognizes the importance of brain imaging in diagnosing neurological disorders and monitoring treatment efficacy, companies are focusing on developing advanced imaging technologies such as MRI, CT, and PET scans. The market is also witnessing an upsurge in partnerships between technology providers and healthcare institutions, which further drives growth and competitiveness as stakeholders aim to deliver state-of-the-art services while addressing regulatory standards and patient safety concerns. As innovations emerge, companies that successfully harness technological advancements are likely to gain a competitive edge and strengthen their market positioning. Toshiba Medical holds significant prominence in the US Brain Imaging Neuroimaging Market, known for its cutting-edge imaging technologies that cater to healthcare providers across the nation. The company’s strengths lie in its commitment to research and development which enables it to deliver high-resolution imaging systems that enhance diagnostic processes. Toshiba Medical's product offerings include advanced MRI and CT systems that are recognized for their reliability and efficacy in clinical settings. The company has established a formidable market presence through strategic partnerships with renowned healthcare institutions, enriching its reputation as a trusted provider of neuroimaging solutions. Furthermore, its ability to integrate user-friendly features and innovative software solutions into its imaging technologies has fostered positive relationships with end-users, thereby solidifying its foothold in the competitive landscape. Plexus Technology also plays a crucial role in the US Brain Imaging Neuroimaging Market, focusing on delivering specialized imaging software solutions that enhance the analysis of neuroimaging data. The company’s key products include advanced imaging analysis tools and cloud-based platforms that improve diagnostic workflows in neuroimaging. Plexus Technology's strengths are rooted in its dedication to optimizing neuroimaging processes through innovative technology, which aids radiologists and neurologists in efficiently interpreting complex data. The company has made strategic moves through mergers and acquisitions, enabling it to expand its product portfolio and access new market avenues within the US. This strategic positioning, combined with a focus on developing advanced algorithms for enhanced image analysis, has established Plexus Technology as a noteworthy competitor in the neuroimaging domain, empowering healthcare professionals to offer superior patient care through more informed decision-making. ### **Key Companies in the US Brain Imaging Neuroimaging Market Include** ## **US Brain Imaging Neuroimaging Market Industry Developments** Recent developments in the US Brain Imaging Neuroimaging Market indicate significant advancements and shifting dynamics. Companies like Siemens Healthineers and General Electric continue to innovate in imaging technologies, enhancing diagnostic capabilities. In June 2023, Brain Scientific launched groundbreaking algorithms designed to improve the interpretation of neural data, showcasing the integration of AI in neuroimaging. Meanwhile, in July 2023, Medtronic disclosed plans to expand its Neurovascular product line, emphasizing the growing demand for advanced imaging solutions in medical interventions. Notably, there were reports in August 2023 of a strategic partnership involving Elekta and Toshiba Medical to develop advanced imaging systems tailored for cancer therapy, enhancing treatment precision. In terms of market value, the US Brain Imaging Market is expected to grow substantially, driven by rising prevalence of neurological disorders. Major players, including Philips Healthcare and Canon Medical Systems, are actively engaging in research collaborations to address these market needs. Over the past two years, the integration of artificial intelligence and deep learning models into imaging analysis has become increasingly prevalent, reflecting the industry's commitment to driving diagnostic accuracy and patient outcomes. ## **US Brain Imaging Neuroimaging Market Segmentation Insights** ### **Brain Imaging Neuroimaging Market Imaging Type Outlook** ### **Brain Imaging Neuroimaging Market End User Outlook** ## Market Drivers ### Growing Awareness of Mental Health Issues The rising awareness of mental health issues in the US is contributing to the expansion of the brain imaging-neuroimaging market. As society becomes more cognizant of the importance of mental health, there is an increasing demand for diagnostic tools that can aid in the assessment of conditions such as depression, anxiety, and schizophrenia. Neuroimaging techniques are being recognized for their potential to provide insights into the biological underpinnings of these disorders. This shift in perception is likely to lead to greater investment in neuroimaging technologies, as healthcare providers seek to incorporate these tools into routine mental health assessments, thereby enhancing the overall efficacy of treatment strategies in the brain imaging-neuroimaging market. ### Increased Funding for Neuroscience Research The surge in funding for neuroscience research is significantly impacting the brain imaging-neuroimaging market. Government agencies and private organizations are allocating substantial resources to understand brain function and develop new treatments for neurological disorders. For instance, the National Institutes of Health (NIH) has increased its budget for brain research, which is expected to exceed $3 billion in the coming fiscal year. This influx of funding is likely to stimulate the development of innovative imaging technologies and methodologies, thereby enhancing the capabilities of the brain imaging-neuroimaging market. As research progresses, the demand for advanced imaging solutions is anticipated to rise, further driving market growth. ### Rising Prevalence of Neurological Disorders The increasing incidence of neurological disorders in the US is a primary driver for the brain imaging-neuroimaging market. Conditions such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis are becoming more prevalent, necessitating advanced imaging techniques for accurate diagnosis and monitoring. According to recent estimates, approximately 6.2 million individuals in the US are living with Alzheimer's, a figure projected to rise significantly in the coming years. This growing patient population is likely to drive demand for neuroimaging technologies, as healthcare providers seek effective methods to assess and manage these conditions. Consequently, The brain imaging-neuroimaging market is expected to expand. This expansion is due to healthcare systems investing in advanced imaging modalities to improve patient outcomes. ### Technological Innovations in Imaging Techniques Technological advancements in imaging modalities are transforming the brain imaging-neuroimaging market. Innovations such as functional MRI (fMRI), positron emission tomography (PET), and advanced CT scans are enhancing the ability to visualize brain activity and structure with unprecedented clarity. These technologies allow for non-invasive assessments, which are crucial for early diagnosis and treatment planning. The market for MRI systems alone is projected to reach approximately $6 billion by 2026. This reflects the growing investment in advanced imaging technologies. As these innovations continue to evolve, they are likely to attract further interest from healthcare providers, thereby propelling the growth of the brain imaging-neuroimaging market. ### Integration of Artificial Intelligence in Imaging The integration of artificial intelligence (AI) in imaging technologies is poised to revolutionize the brain imaging-neuroimaging market. AI algorithms are being developed to analyze complex imaging data, improving diagnostic accuracy and efficiency. These advancements can assist radiologists in identifying abnormalities and patterns that may be overlooked in traditional analyses. The market for AI in medical imaging is projected to grow at a CAGR of over 30% in the next few years, indicating a strong trend towards automation and enhanced decision-making capabilities. As AI continues to be integrated into neuroimaging practices, it is likely to drive demand for advanced imaging solutions, thereby fostering growth in the brain imaging-neuroimaging market. ## Future Outlook The [Brain Imaging Neuroimaging Market](https://www.marketresearchfuture.com/reports/brain-imaging-neuroimaging-market-12265) is projected to grow at a 5.79% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of neurological disorders, and rising healthcare expenditure. **New opportunities:** - Development of AI-driven diagnostic tools for enhanced imaging accuracy. - Expansion of tele-neuroimaging services to reach remote patients. - Partnerships with pharmaceutical companies for integrated imaging solutions. By 2035, the market is expected to achieve substantial growth, driven by innovation and strategic collaborations. ## Segment Insights ### By Imaging Type: fMRI (Largest) vs. EEG (Fastest-Growing) In the US brain imaging-neuroimaging market, the distribution of market share among various imaging types is notable. Functional magnetic resonance imaging (fMRI) holds the largest market share due to its widespread application in both clinical and research settings. Compound tomography (CT) and positron emission tomography (PET) follow, appealing to specific diagnostic needs. Meanwhile, modalities like electroencephalography (EEG) and near infrared spectroscopy (NIRS) have smaller shares but are gaining traction. Growth trends indicate that EEG is the fastest-growing segment as its non-invasive characteristics and real-time monitoring capabilities are increasingly recognized in both research and clinical diagnostics. Additionally, advancements in technology and increasing healthcare expenditure drive the demand across all imaging types. The rise in neurological disorders is prompting a shift towards more complex imaging methods, supporting the market's expansion. fMRI (Dominant) vs. EEG (Emerging) Functional magnetic resonance imaging (fMRI) stands out as the dominant player in the US brain imaging-neuroimaging market due to its ability to provide detailed brain activity maps non-invasively. It is favored in studies of cognitive function, making it integral to both clinical diagnosis and neuroscientific research. In contrast, electroencephalography (EEG) is an emerging modality that excels in measuring electrical brain activity with high temporal resolution. Its growing popularity stems from advancements in technology, making it more accessible and cost-effective. EEG's non-invasive nature adds to its appeal, particularly in monitoring conditions like epilepsy and sleep disorders. As interest in brain health grows, both fMRI and EEG will continue to play significant roles in shaping this dynamic market. ### By End User: Hospitals (Largest) vs. Ambulatory Surgical Centers and Clinics (Fastest-Growing) In the US brain imaging-neuroimaging market, hospitals hold the largest share, accounting for a significant portion of the overall market. This segment dominates due to the comprehensive range of services provided, including advanced imaging technologies and specialized care. Ambulatory surgical centers and clinics are gaining market traction, reflecting a shift toward outpatient services and an increasing number of diagnostic procedures being performed outside traditional hospital settings. Growth trends for these segments are influenced by several key factors, including the rising demand for non-invasive diagnostic techniques and technological advancements in imaging modalities. Hospitals are expanding their services to include the latest neuroimaging technologies, while ambulatory surgical centers and clinics are rapidly adopting these innovations to accommodate the increasing patient volume, thus driving their growth in the market. Hospitals (Dominant) vs. Ambulatory Surgical Centers and Clinics (Emerging) Hospitals are a dominant force in the US brain imaging-neuroimaging market, offering extensive resources, skilled personnel, and access to cutting-edge technology. Their comprehensive care approach ensures high patient trust, leading to increased utilization of imaging services. On the other hand, ambulatory surgical centers and clinics represent an emerging segment, characterized by their ability to provide specialized and efficient imaging services in a more accessible environment. Their rise is fueled by the growing trend of outpatient care, lower operational costs, and enhanced patient convenience. Together, these segments illustrate the evolving landscape of neuroimaging services, with hospitals focusing on advanced technology while ambulatory settings capitalize on accessibility. ## Competitive Benchmarking The brain imaging-neuroimaging market is characterized by a dynamic competitive landscape, driven by technological advancements and increasing demand for diagnostic imaging solutions. Key players such as GE Healthcare (US), Siemens Healthineers (DE), and Philips Healthcare (NL) are at the forefront, each adopting distinct strategies to enhance their market presence. GE Healthcare (US) focuses on innovation through the development of advanced imaging technologies, while Siemens Healthineers (DE) emphasizes strategic partnerships to expand its product offerings. Philips Healthcare (NL) is actively pursuing digital transformation initiatives, integrating AI into its imaging solutions, which collectively shapes a competitive environment that prioritizes technological superiority and customer-centric solutions.In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance operational efficiency. The market structure appears moderately fragmented, with several key players exerting substantial influence. This fragmentation allows for a diverse range of products and services, catering to various customer needs while fostering competition among established and emerging players. In October GE Healthcare (US) announced the launch of its latest MRI system, which incorporates AI-driven analytics to improve diagnostic accuracy. This strategic move not only reinforces GE's commitment to innovation but also positions the company to capture a larger share of the growing demand for advanced imaging solutions. The integration of AI is likely to enhance workflow efficiency and patient outcomes, thereby solidifying GE's competitive edge in the market. In September Siemens Healthineers (DE) entered into a partnership with a leading telehealth provider to enhance remote diagnostic capabilities. This collaboration is strategically significant as it aligns with the increasing trend towards telemedicine, allowing Siemens to expand its reach and offer integrated solutions that cater to the evolving needs of healthcare providers. Such partnerships may prove essential in navigating the complexities of modern healthcare delivery. In August Philips Healthcare (NL) unveiled a new digital platform designed to streamline imaging workflows and improve data management. This initiative reflects Philips' focus on digital transformation and its commitment to enhancing the user experience for healthcare professionals. By leveraging digital technologies, Philips aims to differentiate itself in a competitive market, potentially leading to improved operational efficiencies and better patient care. As of November current competitive trends in the brain imaging-neuroimaging market include a pronounced shift towards digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly shaping the landscape, enabling companies to leverage complementary strengths and enhance their service offerings. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability, underscoring the importance of adaptability in a rapidly changing market. ## Recent News & Developments Recent developments in the US Brain Imaging Neuroimaging Market indicate significant advancements and shifting dynamics. Companies like Siemens Healthineers and General Electric continue to innovate in imaging technologies, enhancing diagnostic capabilities. In June 2023, Brain Scientific launched groundbreaking algorithms designed to improve the interpretation of neural data, showcasing the integration of AI in neuroimaging. Meanwhile, in July 2023, Medtronic disclosed plans to expand its Neurovascular product line, emphasizing the growing demand for advanced imaging solutions in medical interventions. Notably, there were reports in August 2023 of a strategic partnership involving Elekta and Toshiba Medical to develop advanced imaging systems tailored for cancer therapy, enhancing treatment precision. In terms of market value, the US Brain Imaging Market is expected to grow substantially, driven by rising prevalence of neurological disorders. Major players, including Philips Healthcare and Canon Medical Systems, are actively engaging in research collaborations to address these market needs. Over the past two years, the integration of artificial intelligence and deep learning models into imaging analysis has become increasingly prevalent, reflecting the industry's commitment to driving diagnostic accuracy and patient outcomes. ## Report Scope | MARKET SIZE 2024 | 3500.0(USD Million) | | --- | --- | | MARKET SIZE 2025 | 3702.65(USD Million) | | MARKET SIZE 2035 | 6500.0(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.79% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Siemens Healthineers (DE), GE Healthcare (US), Philips Healthcare (NL), Canon Medical Systems (JP), Hitachi Medical Corporation (JP), NeuroLogica Corporation (US), Medtronic (US), Brainlab (DE), Elekta (SE) | | Segments Covered | Imaging Type, End User | | Key Market Opportunities | Advancements in artificial intelligence enhance diagnostic accuracy in the brain imaging-neuroimaging market. | | Key Market Dynamics | Technological advancements drive innovation in brain imaging, enhancing diagnostic capabilities and patient outcomes. | | Countries Covered | US | ## Frequently Asked Questions **Q: What was the overall valuation of the US brain imaging-neuroimaging market in 2024?** A: The overall market valuation was $3500.0 Million in 2024. **Q: What is the projected market valuation for the US brain imaging-neuroimaging market by 2035?** A: The projected valuation for 2035 is $6500.0 Million. **Q: What is the expected CAGR for the US brain imaging-neuroimaging market during the forecast period 2025 - 2035?** A: The expected CAGR during the forecast period 2025 - 2035 is 5.79%. **Q: Which companies are considered key players in the US brain imaging-neuroimaging market?** A: Key players include Siemens Healthineers, GE Healthcare, Philips Healthcare, Canon Medical Systems, and others. **Q: What are the main segments of the US brain imaging-neuroimaging market?** A: The main segments include functional magnetic resonance imaging (FMRI), compound tomography (CT), positron emission tomography (PET), and others. **Q: What was the valuation range for functional magnetic resonance imaging (FMRI) in 2024?** A: The valuation range for FMRI was $700.0 Million to $1300.0 Million in 2024. **Q: How did the valuation for compound tomography (CT) perform in 2024?** A: The valuation for CT ranged from $800.0 Million to $1500.0 Million in 2024. **Q: What is the projected growth for electroencephalography (EEG) in the US brain imaging-neuroimaging market?** A: The valuation for EEG is expected to range from $500.0 Million to $900.0 Million by 2035. **Q: What are the end-user segments in the US brain imaging-neuroimaging market?** A: End-user segments include hospitals, ambulatory surgical centers, clinics, and diagnostic centers. **Q: What was the valuation range for hospitals in the US brain imaging-neuroimaging market in 2024?** A: The valuation range for hospitals was $1400.0 Million to $2600.0 Million in 2024. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-brain-imaging-neuroimaging-market-16748*